BB Biotech’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $178M | Hold |
1,314,428
| – | – | 4.47% | 8 |
|
|
2018
Q4 | $128M | Hold |
1,314,428
| – | – | 4.1% | 9 |
|
|
2018
Q3 | $183M | Sell |
1,314,428
-30,000
| -2% | -$4.17M | 4.84% | 6 |
|
|
2018
Q2 | $167M | Sell |
1,344,428
-50,000
| -4% | -$6.21M | 4.82% | 10 |
|
|
2018
Q1 | $155M | Buy |
1,394,428
+40,000
| +3% | +$4.46M | 4.3% | 12 |
|
|
2017
Q4 | $162M | Hold |
1,354,428
| – | – | 4.56% | 10 |
|
|
2017
Q3 | $190M | Hold |
1,354,428
| – | – | 5.26% | 8 |
|
|
2017
Q2 | $165M | Buy |
1,354,428
+125,000
| +10% | +$15.2M | 5.04% | 7 |
|
|
2017
Q1 | $149M | Hold |
1,229,428
| – | – | 4.88% | 8 |
|
|
2016
Q4 | $150M | Buy |
1,229,428
+50,000
| +4% | +$6.12M | 5.57% | 6 |
|
|
2016
Q3 | $145M | Hold |
1,179,428
| – | – | 5.08% | 7 |
|
|
2016
Q2 | $138M | Buy |
1,179,428
+145,000
| +14% | +$16.9M | 5.44% | 7 |
|
|
2016
Q1 | $144M | Hold |
1,034,428
| – | – | 5.72% | 5 |
|
|
2015
Q4 | $197M | Hold |
1,034,428
| – | – | 5.56% | 6 |
|
|
2015
Q3 | $162M | Buy |
1,034,428
+257,000
| +33% | +$40.2M | 5.13% | 6 |
|
|
2015
Q2 | $141M | Buy |
777,428
+105,000
| +16% | +$19M | 3.81% | 10 |
|
|
2015
Q1 | $117M | Hold |
672,428
| – | – | 3.47% | 11 |
|
|
2014
Q4 | $124M | Sell |
672,428
-55,000
| -8% | -$10.2M | 4.03% | 8 |
|
|
2014
Q3 | $121M | Hold |
727,428
| – | – | 4.9% | 7 |
|
|
2014
Q2 | $114M | Hold |
727,428
| – | – | 5.4% | 7 |
|
|
2014
Q1 | $111M | Sell |
727,428
-30,000
| -4% | -$4.56M | 5.7% | 5 |
|
|
2013
Q4 | $101M | Hold |
757,428
| – | – | 5.38% | 6 |
|
|
2013
Q3 | $88M | Sell |
757,428
-20,698
| -3% | -$2.4M | 4.79% | 6 |
|
|
2013
Q2 | $71.8M | Buy |
+778,126
| New | +$71.8M | 5.17% | 6 |
|